• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Efalizumab Lifts Quality of Life in Just Two Weeks

Article

Winston-Salem, N.C. - After subcutaneous treatment with efalizumab(Raptiva), patients who achieved 50 to 75 percent improvement in PsoriasisArea and Severity Index (PASI) score reported improvement in quality oflife.

Recent Videos
1 KOL is featured in this series.
2 KOLs are featured in this series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
E. James Song is featured in this video series.
E. James Song is featured in this video series.
Related Content
Thyroid Disorders and Their Link to Alopecia Areata

Thyroid Disorders and Their Link to Alopecia Areata

Article
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Podcast
New Insights on Treating Pigmented Actinic Keratoses with Laser Technology

New Insights on Treating Pigmented Actinic Keratoses with Laser Technology

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
Advances in Vitiligo Treatment Focus on Immunomodulatory Pathways, Cellular Grafting, and Emerging Drug Targets

Advances in Vitiligo Treatment Focus on Immunomodulatory Pathways, Cellular Grafting, and Emerging Drug Targets

Article
Review Explores Abrocitinib’s Off-Label Uses

Review Explores Abrocitinib’s Off-Label Uses

Article
© 2024 MJH Life Sciences

All rights reserved.